Navigation Links
Age is not a key factor in cancer survival, but clinical trials exclude older patients
Date:11/6/2008

Age is not an independent factor in cancer survival rates and should not influence decisions about how to treat older patients, according to a study in the November issue of IJCP, the Independent Journal of Clinical Practice.

A team of hospital and University-based researchers from Barcelona, Spain, carried out a detailed study of more than 200 patients diagnosed with cancer.

"We found that there were a number of factors that influence survival rates including physical quality of life and how far the cancer had spread but age was not one of them" says lead researcher Dr Eva Domingo from Hospital Vall d'Hebron.

"Despite this fact, and the challenges that clinicians face from an ageing population, there has been little research into how to treat older cancer patients, who often have complex medical needs because of other health issues.

"They have been systematically excluded from clinical trials for cancer treatments. Although 60 per cent of cancers occur in patients over 65, their participation in clinical trials does not exceed 25 per cent.

"This has made it difficult to predict how older patients will tolerate and respond to the latest cancer treatments and has provided an obstacle to making evidence-based clinical decisions."

Dr Domingo and her colleagues teamed up with researchers from the University of Barcelona to look at 224 patients diagnosed with cancerous tumours.

The patients ranged from 32 to 92 years of age and three-quarters of them were male. Thirty-nine per cent of the patients were under 65 and 61 per cent were 65 or over.

The most common tumours were respiratory (43 per cent) and gastrointestinal (29 per cent). 42 per cent of the patients had a localised tumour.

Just under two-thirds of the patients (62 per cent) died during the one-year follow-up period.

The data from each patient, which included body mass index and quality of life
'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Age, race are among factors that influence carotid-surgery success
2. The Age Factor on the Campaign Trail: When the Going Gets Tough, the Tough Keep Moving
3. Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors
4. Study reveals factors of exceptional health in old age
5. Latest Pistachio Study Reveals Significant Reduction in Markers of Inflammation - an Emerging Risk Factor in Heart Disease
6. Study Reveals Factors of Exceptional Health in Old Age
7. A new relationship between brain derived neurotrophic factor and inflammatory signaling
8. Socioeconomic and treatment factors affect non-Hodgkin lymphoma patients survival
9. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
10. New discovery about growth factor can be breakthrough for cancer research
11. Newly-defined factors may prevent postpartum smoking relapse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 Coco Libre, the Official Coconut Water ... Record at the 104th running of the race. On Sunday, ... served 315 people in one hour—one person about every 10 ... so true to the heart of the Bay Area, so ... luge to the finish line only made sense,” said Jennifer ...
(Date:5/22/2015)... McClean, Virginia (PRWEB) May 22, 2015 ... provider of Health IT solutions, announced today that ... ZH Healthcare is the developer of BlueEHS,a first ... (EHS). BlueEHS offers a customizable Electronic Health Records ... e-Rx, lab interfaces, a telemedicine-enabled comprehensive patient portal, ...
(Date:5/22/2015)... PA (PRWEB) May 22, 2015 According to ... a hub for drug related death, totaling almost 2,500 confirmed ... as reported by state officials, totals 2,489 deaths stemming from ... work out, Pennsylvania loses seven people every day to fatal ... has been singled out as one of the most rife ...
(Date:5/22/2015)... The dentist in West ... they are now offering complimentary consultations to patients ... At consultations, patients can discuss their candidacy for ... treatments can achieve and whether alternative options are ... appointment. If treatments are chosen, patients can start ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all forms of ... in include decks, additions, kitchen remodeling, interior renovations, exterior ... , The redesigned logo is a fresh modern ... includes two geometrical lines that represent the engineering aspect ... used with many things associated with the company. The ...
Breaking Medicine News(10 mins):Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2
... deaths in the United States are linked to behavioral and ... these causal links, of the $2 trillion spent annually on ... is devoted to addressing behavioral and social risk factors. ... and social sciences with a new $500,000 grant from the ...
... between the social impairments found in autism and schizophrenia ... disorders. Autism spectrum disorder (ASD) and schizophrenia are ... in social dysfunction. For many years, this similarity resulted ... were thought to have a childhood version of schizophrenia, ...
... with pancreatic cancer may be one step closer to ... in some cases but not in others, according to ... of the American Association for Cancer Research. ... medicine at the University of Cambridge, utilized a laboratory ...
... , TUESDAY, Feb. 28 (HealthDay News) --,Vegetarians ... cultural reasons may unknowingly be consuming gelatin derived ... new study found. Animal-derived gelatin is a commonly ... used as a thickener in some liquid and semisolid ...
... 2012) A great deal has been learned in the ... Health Initiative (WHI). Hormone therapy (HT) remains the most effective ... there is a growing body of evidence that formulation, route ... produce different effects. It is essential to evaluate ...
... study headed up by the Vall d,Hebron Institute of Oncology ... opening up a parallel dimension to existing treatment options. The ... , demonstrate that by combining two drugs that had already ... stopped working, they boost each other,s efficacy and at the ...
Cached Medicine News:Health News:Training grant targets behavioral and social factors linked to health 2Health News:Training grant targets behavioral and social factors linked to health 3Health News:Study compares traits of autism, schizophrenia 2Health News:Many Vegetarians Unaware of Animal-Derived Gels in Pills 2Health News:The North American Menopause Society (NAMS) reassures many women 2Health News:A giant little step in cancer treatment opening up new therapeutic horizons 2
(Date:5/22/2015)... NEW YORK and KING OF PRUSSIA, ... Hemophilia Foundation (NHF) has awarded CSL Behring ... longstanding and unwavering commitment to advancing science and improving the ... by Paul Perreault , CEO and Managing Director, CSL ... New York City on May 21. ...
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... peer-reviewed publication of the results of the Company,s ... preservative-free eye drops) for the treatment of dry ... (CAE ® ) model.  The exploratory study was ... were previously disseminated by the Company in a ...
(Date:5/22/2015)... 2015  The Mesothelioma Victims Center is incredibly ... get the best possible compensation, and they are also ... rare cancer caused by exposure to asbestos or ... to treatment options such as a recent possible ... Victims Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... 2011 K-V Pharmaceutical Company (the "Company") (NYSE: ... of Obstetricians and Gynecologists (ACOG) and Society for ... and ensure that healthcare providers, patients, and the ...  The information update from ACOG and SMFM confirms ...
... MONTREAL, Oct. 13, 2011 A Medco Health Solutions, ... found that 38 percent of patients prescribed Plavix® (clopidogrel)—an ... and stroke—were also using another drug that would impede ... The analysis also showed that primary care physicians ...
Cached Medicine Technology:K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame....
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... Featuring up to 20 ... examination in the vertical, ... plus the option to ... corneal transillumination., ,Filters include ...
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame....
Medicine Products: